Director/PDMR Shareholding

RNS Number : 1414L
Deltex Medical Group PLC
01 July 2014
 



 
 
Deltex Medical Group plc

("Deltex Medical" or the "Company")

 

Directors' Shareholdings/Issue of equity

 

 

1 July 2014 - Deltex Medical Group plc, the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 438,193 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 11.38 pence per share.

 

The three non-executive directors named below have elected to take 262,446 New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 January 2014 to 30 June 2014.

 

A former non-executive director has elected to take 70,299 New Ordinary Shares in lieu of a cash payment as remuneration for his service to the Company for the period 1 January 2014 to 7 May 2014.

 

In addition to the above, the Company also announces that it has today issued a total of 105,448 New Ordinary Shares to an advisor to the Company at a price of 11.38 pence per share.

 

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company. Admission to trading on AIM and dealings in the New Ordinary Shares are expected to commence on 7 July 2014.  Following the issue of these new shares the Company will have a total of 213,017,689 ordinary shares of 1p each in issue.

 

Following this issue, the relevant directors' beneficial interests are as follows:

 

 

Name of Director

Number of New Ordinary Shares issued in lieu of fees/salary

 

Holding of shares following issue of New Ordinary Shares

 

% of enlarged issued share capital

Nigel Keen

146,454

8,495,254

3.99

Sir Duncan Nichol

57,996

986,912

0.46

Julian Cazalet

57,996

4,592,809

2.16

 

For further information:

 

Deltex Medical Group plc                   

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman              


Ewan Phillips, Chief Executive           


Paul Mitchell, Finance Director           




Nominated Adviser & Broker


Arden Partners plc

020 7614 5900

Chris Hardie                                     


 

Joint Broker

Zeus Capital Limited

Dominic Wilson

John Goold

 

 

 

020 7533 7727

 

Financial Public Relations


Newgate Threadneedle

020 7653 9850

Caroline Forde


Heather Armstrong


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFEDSILIIS
UK 100

Latest directors dealings